A joint Schedule 13G was filed on October 28, 2026, by North Rock Digital, LP, Positivo LLC, and related entities and individuals disclosing beneficial ownership positions in HeartSciences Inc. common stock as of October 21, 2026.

Key Highlights

  • Joint filers: Six reporting persons filed together: North Rock Digital, LP; North Rock Digital GP, LLC; Positivo LLC; Positivo Management LLC; Philip H. Press; and Alexander M. Wlezien.
  • Aggregate stake: Philip H. Press and Alexander M. Wlezien each report shared beneficial ownership of 299,271 shares, representing approximately 6.02% of HeartSciences outstanding common stock.
  • North Rock position: North Rock Digital, LP directly owns 176,461 shares, representing approximately 3.55% of outstanding common stock.
  • Positivo position: Positivo LLC directly owns 122,810 shares, representing approximately 2.47% of outstanding common stock.
  • Share base used: All percentages are calculated based on 4,969,283 shares of common stock outstanding as of October 8, 2026, as disclosed in the issuer's definitive proxy statement filed with the SEC on October 19, 2026.
  • Voting and dispositive power: All reporting persons report zero sole voting or dispositive power; all power is shared across the relevant entities and individuals.

HeartSciences Schedule 13G: North Rock and Positivo Ownership Disclosure

According to the filing, North Rock Digital, LP, a Delaware limited partnership, directly holds 176,461 shares of HeartSciences Inc. common stock, par value $0.001 per share (CUSIP 42254E104). North Rock Digital GP, LLC, as the general partner of North Rock, is reported to share voting and dispositive power over those shares. Philip H. Press and Alexander M. Wlezien, described in the filing as holders of the managing membership interests of North Rock GP and persons having ultimate authority over investment and trading decisions, are also reported to share voting and dispositive power over the North Rock shares.

Separately, Positivo LLC, a Puerto Rico limited liability company, directly owns 122,810 shares of HeartSciences common stock. Positivo Management LLC, identified as the investment manager of Positivo and also organized in Puerto Rico, is reported to share voting and dispositive power over those shares. Press and Wlezien, described as members and Co-Chief Investment Officers of Positivo Management with authority to make and implement investment and trading decisions, are also reported to share voting and dispositive power over the Positivo shares. Combined, Press and Wlezien are each reported to beneficially own 299,271 shares, or approximately 6.02% of outstanding common stock.

The filing states that it "shall not be construed as an admission that any Reporting Person is, for purposes of Section 13(d) or 13(g) of the Exchange Act or otherwise, the beneficial owner of any securities reported herein as beneficially owned by such Reporting Person, except to the extent of such Reporting Person's pecuniary interest therein." The filing also notes that the joint filing "shall not be construed as an admission that any of the Reporting Persons constitute or have formed a 'group'" under applicable Exchange Act provisions. The issuer's principal executive offices are listed as 550 Reserve St., Suite 360, Southlake, Texas 76092.

What Was Disclosed

Six related entities and individuals filed a joint Schedule 13G disclosing ownership of HeartSciences Inc. common stock as of October 21, 2026. North Rock Digital, LP holds 176,461 shares (3.55%) and Positivo LLC holds 122,810 shares (2.47%), with Press and Wlezien each reporting a combined 299,271 shares (6.02%).